RetractedArticleExperimental and therapeutic medicine2018

Toll-like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor-κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis.

Yongqiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.